PHIBRO ANIMAL HEALTH CORP 8-K

What Happened

• Phibro Animal Health Corporation announced that Daniel (“Dani”) Bendheim will become Chief Executive Officer and President effective July 1, 2026. The Compensation Committee approved an employment agreement and an initial award of 300,000 restricted stock units (RSUs) under the company’s 2008 Incentive Plan.
• The employment agreement sets Mr. Bendheim’s base salary at $850,000, with a target annual discretionary bonus equal to 50% of base salary and eligibility for annual time‑vesting RSU awards with a target value of approximately 50% of base salary.

Key Details

• Start date: July 1, 2026 (appointment approved June 25, 2026).
• Compensation: $850,000 base salary; target annual bonus = 50% of base; target annual equity ≈ 50% of base.
• Initial RSUs: 300,000 performance‑based RSUs vesting on June 30, 2031 in 25% increments (with interpolation) based on a 90‑day average closing stock price; 0% vests below $70, 100% vests at $100 or above.
• Separation & change‑in‑control: Six months’ salary payable on death/disability; up to 18 months company‑subsidized COBRA for certain terminations; unvested RSUs fully vest on certain change‑in‑control outcomes or if a qualifying termination occurs within 12 months after a change in control.

Why It Matters

• A new CEO is a material leadership change that can affect strategy and execution; investors should note the effective date and the structure of his incentives.
• Compensation is heavily equity‑linked and tied to stock price performance (vesting thresholds between $70 and $100), aligning pay with share‑price outcomes and limiting vesting unless stock performance meets set targets.
• The 300,000 RSU grant represents potential future dilution if vested and settled; change‑in‑control and termination provisions can accelerate vesting, which investors should monitor in a sale or takeover scenario.

(Full Employment Agreement and RSU Award Agreement will be filed as exhibits to the company’s Form 10‑K for the fiscal year ended June 30, 2026.)